MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$214,068K
GB
$198K
Revenue
$214,266K
Income (loss) from
operations
$29,267K
Other income
$3,414K
Total operating
expenses
$184,999K
Income (loss) before
income taxes
$32,681K
Collaboration expenses
$75,577K
Selling, general and
administrative
$61,151K
Research and development
$27,475K
Cost of goods sold
$20,796K
Net income (loss)
$22,592K
Provision for income taxes
$10,089K
Total comprehensive
income (loss)
$21,952K
Total other
comprehensive income (loss)
-$640K
Unrealized gain (loss) on
short-term investments and...
-$640K
Back
Back
Income Statement
source: myfinsight.com
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA)